Transaction in Own Shares

2nd Oct 2025 07:00

RNS Number : 7198B
Currys PLC
02 October 2025
 

2 October 2025

 

Currys Plc (the 'Company')

 

Transaction in Own Shares

and

Total Voting Rights

 

The Company announces that in accordance with the authority given by its shareholders at its Annual General Meeting on 4 September 2025 and pursuant to the Company's share buy-back announced on 4 September 2025, it has purchased for cancellation through Panmure Liberum Limited, the following ordinary shares in the capital of the Company ("Ordinary Shares"):

 

Date of purchase:

1 October 2025

Aggregate number of Ordinary Shares purchased:

481,595

Lowest price paid per share (p):

139.00

Highest price paid per share (p):

139.20

Average price paid per share (p):

139.20

 

Following cancellation of the above Ordinary Shares, the Company will have 1,122,302,662 Ordinary Shares in issue. No Ordinary Shares are held in treasury.

This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

Dan Homan 

Investor Relations Director

+44 (0)7401 400 442

 

Transaction details

Issuer name: Currys Plc

LEI: 2138001E12GWLLDQQF16

ISIN: GB00B4Y7R145

Classification: 2.4. Acquisition or disposal of the issuer's own shares

Intermediary name: Panmure Liberum Limited

Intermediary Code: PMURGB3L

Timezone: BST

Currency: GBp

 

Aggregate Information:

Venue

Daily weighted average price of shares acquired (GBp)

Daily total volume (in number of shares)

XLON

139.20

480,000

CHIX

139.00

1,595

 

Individual Transactions

Transaction Time

Volume

Price

Venue

09:38:20

480000

139.2

XLON

10:20:37

1595

139

CHIX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDFLFBEBLXFBD